- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04829955
Eccentric Manual Resistance Training in Patients With Ischemic CMP
Eccentric Manual Resistance Training for Improvement of Strength and Function in Patients With Ischemic Cardiomyopathy and Mildly Reduced Ejection Fraction
Patients with ischemic cardiomyopathy and mildly reduced ejection fraction suffer from reduced functional capacity and fatigue caused by loss of muscle strength and reduced aerobic capacity.
A few studies have shown that structured endurance and resistance training programs were able to improve walking capacity and limb strength.
Although both concentric and eccentric training programs are beneficial for these patients, eccentric training is less stressful to the cardiovascular system.
The aim of the study is to determine if eccentric-orientated body weight and manual resistance training in ischemic cardiomyopathy patients will lead to superior results compared to concentric training.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BACKGROUND: Eccentric resistance training demonstrated positive effects in ischemic cardiomyopathy patients in several studies. These studies were mainly set on device-based training interventions comparing eccentric-orientated and concentric-orientated training. Eccentric-orientated training induced comparable positive effects on cardiac and functional levels and even better effects on muscle strength improvement.
RESEARCH AIMS: The aim of the study is to determine if eccentric-orientated body weight and manual resistance training in ischemic cardiomyopathy patients will allow a more significant improvement in maximum voluntary contraction force of the knee extensors compared to concentric training.
In contrast to previous studies, these interventions will be set without use of training devices.
In addition, changes in the muscle cross section of the quadriceps muscle will be calculated by skeletal muscle ultrasound. Functional changes and quality of life will be assessed using one minute sit to stand test, six minutes walking test and Kansas City Cardiomyopathy Questionnaire. Cardiac outcome parameters will be assessed by using body composition and hemodynamic parameters as well as echocardiography, laboratory values and specific biomarkers for sarcopenia / cachexia.
METHODS: The investigators propose to run a monocentric, prospective, double arm, open, randomized controlled trial. Eccentric-orientated training will be delivered to 30 ischemic cardiomyopathy patients.
These patients will be randomized into two groups at the beginning, followed by a 6-weeks observation phase (without intervention for internal quality control of the measurement parameters). The intervention-phase will consist of six weeks of three times weekly either eccentric or concentric-oriented training.
Outcome measurements will take place after randomization, after 6 weeks of observation as well as after the intervention phase
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1160
- Klinik Ottakring
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male / female, 45-85a
- Ischemic cardiomyopathy with mildly reduced ejection fraction (40 -50%)
- Coronary heart disease
Exclusion Criteria:
- Acute coronary syndrome, myocarditis or pericarditis in the last 3 months
- Cardiac decompensation in the last 3 months
- Severe symptomatic heart failure NYHA IV (New York Heart Association)
- Device - carrier (ICD= Intracardial Defibrillator, CRT= Cardiac Resynchronization Therapy, PM=Pacemaker)
- Hemodynamically significant valvular disease
- Symptomatic cardiac arrhythmia
- Intractable, uncontrolled hypertension (repetitive blood pressure > 150/100)
- Severe comorbidities, which lead to study exclusion by the investigator
- Pregnancy / nursing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Observation phase
After screening and randomization for either the eccentric orientated intervention group or the concentric orientated intervention group, all measurements will be made for the first time by investigators at point A1.
An observational phase for six weeks will follow to achieve an intern acceptance sampling for the measurements which will be used.
|
|
|
Active Comparator: Eccentric training group
Subjects in the eccentric training group (GEC) will attend six weeks of eccentric orientated training. The eccentric orientated training will use the cadence 3-0-1 for eccentric - break - concentric.
|
Eccentric bodyweight resistance training
|
|
Active Comparator: Concentric training group
The concentric training group (GCO) will attend six weeks of concentric orientated training. Each group will perform a manual resistance/bodyweight resistance training accentuating the concentric phase of the movement. The concentric orientated training will use the cadence 1-0-3 for eccentric - break - concentric.
|
Concentric bodyweight resistance training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MVC of knee-extensors isometric
Time Frame: Baseline
|
Knee dynamometer
|
Baseline
|
|
MVC of knee-extensors isometric
Time Frame: After 6 weeks of observation
|
Knee dynamometer
|
After 6 weeks of observation
|
|
MVC of knee-extensors isometric
Time Frame: After 6 weeks of training
|
Knee dynamometer
|
After 6 weeks of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement
Time Frame: Baseline
|
Sonographic measurement
|
Baseline
|
|
Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement
Time Frame: After 6 weeks of observation
|
Sonographic measurement
|
After 6 weeks of observation
|
|
Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement
Time Frame: After 6 weeks of training
|
Sonographic measurement
|
After 6 weeks of training
|
|
Six- minutes walking test (6MWT)
Time Frame: Baseline
|
Measures the walking distance within 6 minutes.
|
Baseline
|
|
Six- minutes walking test (6MWT)
Time Frame: After 6 weeks of observation
|
Measures the walking distance within 6 minutes.
|
After 6 weeks of observation
|
|
Six- minutes walking test (6MWT)
Time Frame: After 6 weeks of training
|
Measures the walking distance within 6 minutes.
|
After 6 weeks of training
|
|
One-minute sit to stand test
Time Frame: Baseline
|
Measures sit to stand repetitions within one minute.
|
Baseline
|
|
One-minute sit to stand test
Time Frame: After 6 weeks of observation
|
Measures sit to stand repetitions within one minute.
|
After 6 weeks of observation
|
|
One-minute sit to stand test
Time Frame: After 6 weeks of training
|
Measures sit to stand repetitions within one minute.
|
After 6 weeks of training
|
|
Quality of life (QoL)
Time Frame: Baseline
|
Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains.
For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established.
Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
|
Baseline
|
|
Quality of life (QoL)
Time Frame: After 6 weeks of observation
|
Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains.
For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established.
Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
|
After 6 weeks of observation
|
|
Quality of life (QoL): questionnaire
Time Frame: After 6 weeks of training
|
Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains.
For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established.
Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
|
After 6 weeks of training
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Walter Bily, MD, Vienna HA
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cardio eccentric protocol 3.5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Cardiomyopathy
-
Cedars-Sinai Medical CenterWithdrawnIschemic Cardiomyopathy | Chronic Ischemic CardiomyopathyUnited States
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruitingNon-ischemic CardiomyopathyChina
-
Celladon CorporationCompletedHeart Failure | Cardiomyopathies | Ischemic Cardiomyopathy | Non-ischemic CardiomyopathyUnited States, United Kingdom, Belgium, Germany, Poland, Israel, Netherlands, Hungary, Denmark, Sweden
-
Universitaire Ziekenhuizen KU LeuvenRecruitingHeart Failure | Ischemic Cardiomyopathy | Non-ischemic CardiomyopathyBelgium
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingCell Therapy | Ischemic Cardiomyopathy
-
Celladon CorporationTerminatedHeart Failure | Cardiomyopathies | Ischemic Cardiomyopathy | Non-ischemic CardiomyopathyUnited States
-
Rabin Medical CenterUnknownHeart Failure | Ischemic Cardiomyopathy | Non-ischemic CardiomyopathyIsrael
-
Assistance Publique - Hôpitaux de ParisCelladon CorporationTerminatedIschemic Cardiomyopathy | Non-ischemic Cardiomyopathy | Heart Failure CongestiveFrance
-
University of Cape TownMedtronicSuspendedDilated Cardiomyopathy | Ischemic Cardiomyopathy | Non-ischemic CardiomyopathySouth Africa
-
Duke UniversityCompletedCardiomyopathy (Ischemic or Non-Ischemic)United States
Clinical Trials on Eccentric manual resistance training
-
Riphah International UniversityCompleted
-
University of CopenhagenCompleted
-
University of Colorado, DenverNIH/NCATS Colorado CTSA Grant Number T32TR004367RecruitingKnee Arthritis, OsteoarthritisUnited States
-
Universidad Nacional Andres BelloRecruitingAcromioclavicular Joint Dislocation | Acromioclavicular Joint InjuryChile
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Mustafa Kemal UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingSubacromial Impingement Syndrome | Bicep Tendinitis | Rotator Cuff TendinopathyTurkey
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
Hungarian University of Sports ScienceSemmelweis UniversityActive, not recruiting
-
University of CalgaryUnknown
-
New Damietta University HospitalCompletedSports PerformanceEgypt